Invention Grant
US08728471B2 Antibody therapy for treatment of diseases associated with gluten intolerance
有权
用于治疗与麸质不耐症有关的疾病的抗体治疗
- Patent Title: Antibody therapy for treatment of diseases associated with gluten intolerance
- Patent Title (中): 用于治疗与麸质不耐症有关的疾病的抗体治疗
-
Application No.: US13290335Application Date: 2011-11-07
-
Publication No.: US08728471B2Publication Date: 2014-05-20
- Inventor: Barbara S. Fox
- Applicant: Barbara S. Fox
- Applicant Address: US MA Lexington
- Assignee: Avaxia Biologics, Incorporated
- Current Assignee: Avaxia Biologics, Incorporated
- Current Assignee Address: US MA Lexington
- Agency: Elmore Patent Law Group, P.C.
- Agent Darlene A. Vanstone, Esq.; Carolyn S. Elmore, Esq.
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention includes a pharmaceutical compositions and methods for treating diseases associated with gluten intolerance in a patient, comprising: administering to the patient an effective amount of an antibody having specific activity against gluten or gluten-derived peptides. Such diseases include, for example, celiac disease and dermatitis herpetiformis.
Public/Granted literature
- US20120114653A1 ANTIBODY THERAPY FOR TREATMENT OF DISEASES ASSOCIATED WITH GLUTEN INTOLERANCE Public/Granted day:2012-05-10
Information query
